Actavis Launches Generic Version of Catapres-TTS®

[PR Newswire] – DUBLIN, May 7, 2014 /PRNewswire/ — Actavis plc (NYSE: ACT) today announced that it has launched a generic version of Boehringer Ingelheim’s Catapres-TTS ® (Clonidine Transdermal System, USP, 0.1 mg/day, … more

View todays social media effects on ACT

View the latest stocks trending across Twitter. Click to view dashboard

See who Actavis is hiring next, click here to view